Objective:

To provide an overview of hereditary hemorrhagic telangiectasia (HHT), including its causes, symptoms, diagnosis, and management.

Approach:

Key Findings:

• HHT is underrecognized and often diagnosed late.
• 90% of patients experience recurrent nosebleeds.
• AVMs can lead to serious complications, including stroke and heart failure.

Interpretation:

Early diagnosis and management of HHT are crucial to prevent severe complications associated with AVMs.

Limitations:

• HHT is frequently underdiagnosed due to lack of awareness.
• Symptoms may not appear until later in life, complicating early detection.

Conclusion:

Understanding HHT is vital for timely diagnosis and management to mitigate risks associated with the disorder.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.